ALB and metabolic dysfunction-associated steatotic liver disease: Patients with MASLD–NAFLD had a higher level of albumin (44.0 vs 41.0 g/L), TBil (9.10 vs 7.65 μmol/L), and fasting glucose (4.80 vs 4.60 mmol/L) than patients with MAFLD-only.